Literature DB >> 10816382

Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.

X Xiao1, D Norwood, Y R Feng, M Moriuchi, A Jones-Trower, T S Stantchev, H Moriuchi, C C Broder, D S Dimitrov.   

Abstract

Certain subclones (designated as minus clones) of the promonocytic U937 cell line do not support efficient infection and fusion mediated by T cell line adapted (TCLA) X4 HIV-1 gp120-gp41 (Env) although the CXCR4 and CD4 concentrations at their surfaces are similar to those at the surfaces of clones susceptible to HIV-1 entry (plus clones) (H. Moriuchi et al., J. Virol. 71, 9664-9671, 1997). To test the hypothesis that inefficient formation of gp120-CD4-CXCR4 complexes could contribute to the mechanism of resistance to Env-mediated fusion in the minus clones, we incubated plus and minus cells with HIV-1 LAI gp120 and coimmunoprecipitated CD4 by using anti-CXCR4 antibodies. The gp120 induced inefficient coimmunoprecipitation of CD4 in the minus clones but not in the plus ones. Overexpression of CD4 resulted in significant restoration of the minus clones' susceptibility to fusion in parallel with an increase in the amount of the gp120-CD4-CXCR4 complexes. These results not only suggest that the resistance to TCLA X4 HIV-1 entry in the U937 minus clones is due to the inability of these cells to efficiently form complexes among CD4, gp120, and CXCR4, but also provide a direct evidence for the correlation between fusion and the cell surface concentration of the complexes among CXCR4, CD4, and gp120. These data and similar recent observations in macrophages suggest that inefficient complex formation among CXCR4, CD4, and gp120 could be a general mechanism of cell resistance to gp120-gp41-mediated fusion and a major determinant of HIV-1 evolution in vivo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816382     DOI: 10.1006/exmp.1999.2299

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  8 in total

1.  Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion.

Authors:  Janet E Lineberger; Renee Danzeisen; Daria J Hazuda; Adam J Simon; Michael D Miller
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection.

Authors:  Agustín Valenzuela-Fernández; Susana Alvarez; Mónica Gordon-Alonso; Marta Barrero; Angeles Ursa; J Román Cabrero; Gerónimo Fernández; Salvador Naranjo-Suárez; Maria Yáñez-Mo; Juan M Serrador; M Angeles Muñoz-Fernández; Francisco Sánchez-Madrid
Journal:  Mol Biol Cell       Date:  2005-09-07       Impact factor: 4.138

3.  The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.

Authors:  Tzanko S Stantchev; Ingrid Markovic; William G Telford; Kathleen A Clouse; Christopher C Broder
Journal:  Virus Res       Date:  2006-10-09       Impact factor: 3.303

4.  Antigenically distinct conformations of CXCR4.

Authors:  F Baribaud; T G Edwards; M Sharron; A Brelot; N Heveker; K Price; F Mortari; M Alizon; M Tsang; R W Doms
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages.

Authors:  Jana J von Lindern; Daniel Rojo; Kathie Grovit-Ferbas; Christine Yeramian; Cheng Deng; Georges Herbein; Monique R Ferguson; Todd C Pappas; Julie M Decker; Anjali Singh; Ronald G Collman; William A O'Brien
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.

Authors:  George Lin; Frédéric Baribaud; Josephine Romano; Robert W Doms; James A Hoxie
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases.

Authors:  K F Ferri; E Jacotot; J Blanco; J A Esté; N Zamzami; S A Susin; Z Xie; G Brothers; J C Reed; J M Penninger; G Kroemer
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

Review 8.  Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm.

Authors:  Gregory B Melikyan
Journal:  Retrovirology       Date:  2008-12-10       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.